nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamsulosin—ORM1—Vemurafenib—melanoma	0.398	0.615	CbGbCtD
Tamsulosin—CYP3A4—Temozolomide—melanoma	0.0959	0.148	CbGbCtD
Tamsulosin—CYP2D6—Vemurafenib—melanoma	0.0826	0.128	CbGbCtD
Tamsulosin—CYP3A4—Vemurafenib—melanoma	0.0525	0.0811	CbGbCtD
Tamsulosin—CYP3A4—Docetaxel—melanoma	0.018	0.0278	CbGbCtD
Tamsulosin—Carvedilol—HIF1A—melanoma	0.00382	0.472	CrCbGaD
Tamsulosin—Drug interaction—Carmustine—melanoma	0.00181	0.00946	CcSEcCtD
Tamsulosin—Infestation NOS—Vemurafenib—melanoma	0.00178	0.00928	CcSEcCtD
Tamsulosin—Infestation—Vemurafenib—melanoma	0.00178	0.00928	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00177	0.0092	CcSEcCtD
Tamsulosin—Neck pain—Carmustine—melanoma	0.0017	0.00888	CcSEcCtD
Tamsulosin—Skin exfoliation—Carmustine—melanoma	0.00161	0.00838	CcSEcCtD
Tamsulosin—Silodosin—ABCB1—melanoma	0.0016	0.199	CrCbGaD
Tamsulosin—Influenza like illness—Temozolomide—melanoma	0.00158	0.00824	CcSEcCtD
Tamsulosin—Oedema peripheral—Vemurafenib—melanoma	0.00157	0.00821	CcSEcCtD
Tamsulosin—Connective tissue disorder—Vemurafenib—melanoma	0.00157	0.00819	CcSEcCtD
Tamsulosin—Skin exfoliation—Temozolomide—melanoma	0.00155	0.0081	CcSEcCtD
Tamsulosin—Carvedilol—VEGFA—melanoma	0.00154	0.19	CrCbGaD
Tamsulosin—Injury—Bleomycin—melanoma	0.00152	0.00794	CcSEcCtD
Tamsulosin—Erythema multiforme—Vemurafenib—melanoma	0.00151	0.00788	CcSEcCtD
Tamsulosin—Cardiac disorder—Vemurafenib—melanoma	0.00148	0.00773	CcSEcCtD
Tamsulosin—Angiopathy—Vemurafenib—melanoma	0.00145	0.00756	CcSEcCtD
Tamsulosin—Mediastinal disorder—Vemurafenib—melanoma	0.00144	0.00751	CcSEcCtD
Tamsulosin—Arthritis—Bleomycin—melanoma	0.00144	0.00751	CcSEcCtD
Tamsulosin—Chills—Vemurafenib—melanoma	0.00143	0.00748	CcSEcCtD
Tamsulosin—Malnutrition—Vemurafenib—melanoma	0.00139	0.00725	CcSEcCtD
Tamsulosin—Back pain—Vemurafenib—melanoma	0.00135	0.00702	CcSEcCtD
Tamsulosin—Rhinorrhoea—Docetaxel—melanoma	0.00134	0.00696	CcSEcCtD
Tamsulosin—Injury—Carmustine—melanoma	0.00133	0.00693	CcSEcCtD
Tamsulosin—Nasal congestion—Temozolomide—melanoma	0.0013	0.00676	CcSEcCtD
Tamsulosin—Dermatitis exfoliative—Temozolomide—melanoma	0.00125	0.00652	CcSEcCtD
Tamsulosin—Cough—Vemurafenib—melanoma	0.00121	0.00633	CcSEcCtD
Tamsulosin—Arthralgia—Vemurafenib—melanoma	0.00118	0.00618	CcSEcCtD
Tamsulosin—Myalgia—Vemurafenib—melanoma	0.00118	0.00618	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00118	0.00613	CcSEcCtD
Tamsulosin—Drug interaction—Docetaxel—melanoma	0.00117	0.00608	CcSEcCtD
Tamsulosin—Infection—Vemurafenib—melanoma	0.00113	0.00588	CcSEcCtD
Tamsulosin—Nervous system disorder—Vemurafenib—melanoma	0.00111	0.00581	CcSEcCtD
Tamsulosin—Skin disorder—Vemurafenib—melanoma	0.0011	0.00575	CcSEcCtD
Tamsulosin—Breast disorder—Temozolomide—melanoma	0.00107	0.00556	CcSEcCtD
Tamsulosin—Hypotension—Vemurafenib—melanoma	0.00106	0.00553	CcSEcCtD
Tamsulosin—Influenza like illness—Docetaxel—melanoma	0.00105	0.00548	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00103	0.00539	CcSEcCtD
Tamsulosin—Skin exfoliation—Docetaxel—melanoma	0.00103	0.00538	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000998	0.0052	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000981	0.00511	CcSEcCtD
Tamsulosin—Fatigue—Vemurafenib—melanoma	0.000979	0.0051	CcSEcCtD
Tamsulosin—Constipation—Vemurafenib—melanoma	0.000971	0.00506	CcSEcCtD
Tamsulosin—Lightheadedness—Docetaxel—melanoma	0.000968	0.00505	CcSEcCtD
Tamsulosin—Dysuria—Temozolomide—melanoma	0.000954	0.00498	CcSEcCtD
Tamsulosin—Erectile dysfunction—Temozolomide—melanoma	0.00094	0.0049	CcSEcCtD
Tamsulosin—Urinary tract infection—Carmustine—melanoma	0.000915	0.00477	CcSEcCtD
Tamsulosin—Infestation—Temozolomide—melanoma	0.00091	0.00474	CcSEcCtD
Tamsulosin—Infestation NOS—Temozolomide—melanoma	0.00091	0.00474	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000902	0.0047	CcSEcCtD
Tamsulosin—Body temperature increased—Vemurafenib—melanoma	0.000898	0.00468	CcSEcCtD
Tamsulosin—Pharyngitis—Dactinomycin—melanoma	0.000897	0.00467	CcSEcCtD
Tamsulosin—Urinary tract infection—Temozolomide—melanoma	0.000885	0.00461	CcSEcCtD
Tamsulosin—Chills—Bleomycin—melanoma	0.000869	0.00453	CcSEcCtD
Tamsulosin—Erythema multiforme—Dactinomycin—melanoma	0.000854	0.00445	CcSEcCtD
Tamsulosin—Sinusitis—Temozolomide—melanoma	0.000854	0.00445	CcSEcCtD
Tamsulosin—Hypersensitivity—Vemurafenib—melanoma	0.000837	0.00436	CcSEcCtD
Tamsulosin—Oedema peripheral—Carmustine—melanoma	0.000833	0.00434	CcSEcCtD
Tamsulosin—Connective tissue disorder—Carmustine—melanoma	0.000831	0.00433	CcSEcCtD
Tamsulosin—Atrial fibrillation—Docetaxel—melanoma	0.000829	0.00432	CcSEcCtD
Tamsulosin—Asthenia—Vemurafenib—melanoma	0.000815	0.00425	CcSEcCtD
Tamsulosin—Visual impairment—Carmustine—melanoma	0.000815	0.00425	CcSEcCtD
Tamsulosin—Pharyngitis—Temozolomide—melanoma	0.000811	0.00423	CcSEcCtD
Tamsulosin—Chills—Dactinomycin—melanoma	0.000811	0.00422	CcSEcCtD
Tamsulosin—Oedema peripheral—Temozolomide—melanoma	0.000805	0.0042	CcSEcCtD
Tamsulosin—Pruritus—Vemurafenib—melanoma	0.000804	0.00419	CcSEcCtD
Tamsulosin—Connective tissue disorder—Temozolomide—melanoma	0.000803	0.00418	CcSEcCtD
Tamsulosin—Visual impairment—Temozolomide—melanoma	0.000787	0.0041	CcSEcCtD
Tamsulosin—Ill-defined disorder—Bleomycin—melanoma	0.000782	0.00408	CcSEcCtD
Tamsulosin—Diarrhoea—Vemurafenib—melanoma	0.000777	0.00405	CcSEcCtD
Tamsulosin—Erythema multiforme—Temozolomide—melanoma	0.000773	0.00403	CcSEcCtD
Tamsulosin—Malaise—Bleomycin—melanoma	0.00076	0.00396	CcSEcCtD
Tamsulosin—Cardiac disorder—Temozolomide—melanoma	0.000758	0.00395	CcSEcCtD
Tamsulosin—Arrhythmia—Carmustine—melanoma	0.000755	0.00394	CcSEcCtD
Tamsulosin—Dizziness—Vemurafenib—melanoma	0.000751	0.00391	CcSEcCtD
Tamsulosin—Angiopathy—Temozolomide—melanoma	0.000741	0.00386	CcSEcCtD
Tamsulosin—Mediastinal disorder—Temozolomide—melanoma	0.000736	0.00384	CcSEcCtD
Tamsulosin—Malnutrition—Carmustine—melanoma	0.000736	0.00384	CcSEcCtD
Tamsulosin—Cough—Bleomycin—melanoma	0.000736	0.00384	CcSEcCtD
Tamsulosin—Chills—Temozolomide—melanoma	0.000733	0.00382	CcSEcCtD
Tamsulosin—Ill-defined disorder—Dactinomycin—melanoma	0.00073	0.0038	CcSEcCtD
Tamsulosin—Bumetanide—PTGS2—melanoma	0.000727	0.09	CrCbGaD
Tamsulosin—Vomiting—Vemurafenib—melanoma	0.000722	0.00376	CcSEcCtD
Tamsulosin—Chest pain—Bleomycin—melanoma	0.000718	0.00374	CcSEcCtD
Tamsulosin—Myalgia—Bleomycin—melanoma	0.000718	0.00374	CcSEcCtD
Tamsulosin—Orthostatic hypotension—Docetaxel—melanoma	0.000717	0.00374	CcSEcCtD
Tamsulosin—Rash—Vemurafenib—melanoma	0.000716	0.00373	CcSEcCtD
Tamsulosin—Dermatitis—Vemurafenib—melanoma	0.000715	0.00373	CcSEcCtD
Tamsulosin—Back pain—Carmustine—melanoma	0.000712	0.00371	CcSEcCtD
Tamsulosin—Headache—Vemurafenib—melanoma	0.000712	0.00371	CcSEcCtD
Tamsulosin—Malnutrition—Temozolomide—melanoma	0.000711	0.00371	CcSEcCtD
Tamsulosin—Breast disorder—Docetaxel—melanoma	0.00071	0.0037	CcSEcCtD
Tamsulosin—Discomfort—Bleomycin—melanoma	0.000709	0.0037	CcSEcCtD
Tamsulosin—Malaise—Dactinomycin—melanoma	0.000709	0.0037	CcSEcCtD
Tamsulosin—Nasopharyngitis—Docetaxel—melanoma	0.000702	0.00366	CcSEcCtD
Tamsulosin—Vision blurred—Carmustine—melanoma	0.000694	0.00362	CcSEcCtD
Tamsulosin—Back pain—Temozolomide—melanoma	0.000688	0.00359	CcSEcCtD
Tamsulosin—Infection—Bleomycin—melanoma	0.000684	0.00356	CcSEcCtD
Tamsulosin—Nausea—Vemurafenib—melanoma	0.000675	0.00352	CcSEcCtD
Tamsulosin—Vision blurred—Temozolomide—melanoma	0.00067	0.00349	CcSEcCtD
Tamsulosin—Myalgia—Dactinomycin—melanoma	0.000669	0.00349	CcSEcCtD
Tamsulosin—Discomfort—Dactinomycin—melanoma	0.000661	0.00345	CcSEcCtD
Tamsulosin—Ill-defined disorder—Temozolomide—melanoma	0.00066	0.00344	CcSEcCtD
Tamsulosin—Angioedema—Temozolomide—melanoma	0.00065	0.00339	CcSEcCtD
Tamsulosin—Hypotension—Bleomycin—melanoma	0.000643	0.00335	CcSEcCtD
Tamsulosin—Malaise—Temozolomide—melanoma	0.000641	0.00334	CcSEcCtD
Tamsulosin—Vertigo—Temozolomide—melanoma	0.000639	0.00333	CcSEcCtD
Tamsulosin—Infection—Dactinomycin—melanoma	0.000638	0.00332	CcSEcCtD
Tamsulosin—Hypertension—Carmustine—melanoma	0.000635	0.00331	CcSEcCtD
Tamsulosin—Palpitations—Temozolomide—melanoma	0.000629	0.00328	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000627	0.00327	CcSEcCtD
Tamsulosin—Chest pain—Carmustine—melanoma	0.000627	0.00327	CcSEcCtD
Tamsulosin—Myalgia—Carmustine—melanoma	0.000627	0.00327	CcSEcCtD
Tamsulosin—Cough—Temozolomide—melanoma	0.000621	0.00324	CcSEcCtD
Tamsulosin—Paraesthesia—Bleomycin—melanoma	0.000618	0.00322	CcSEcCtD
Tamsulosin—Hypertension—Temozolomide—melanoma	0.000614	0.0032	CcSEcCtD
Tamsulosin—Dyspnoea—Bleomycin—melanoma	0.000613	0.0032	CcSEcCtD
Tamsulosin—Myalgia—Temozolomide—melanoma	0.000606	0.00316	CcSEcCtD
Tamsulosin—Arthralgia—Temozolomide—melanoma	0.000606	0.00316	CcSEcCtD
Tamsulosin—Infestation NOS—Docetaxel—melanoma	0.000605	0.00315	CcSEcCtD
Tamsulosin—Infestation—Docetaxel—melanoma	0.000605	0.00315	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000601	0.00313	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.0006	0.00313	CcSEcCtD
Tamsulosin—Discomfort—Temozolomide—melanoma	0.000598	0.00312	CcSEcCtD
Tamsulosin—Infection—Carmustine—melanoma	0.000597	0.00311	CcSEcCtD
Tamsulosin—Pain—Bleomycin—melanoma	0.000588	0.00307	CcSEcCtD
Tamsulosin—Tachycardia—Carmustine—melanoma	0.000586	0.00306	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000585	0.00305	CcSEcCtD
Tamsulosin—Infection—Temozolomide—melanoma	0.000577	0.00301	CcSEcCtD
Tamsulosin—Epistaxis—Docetaxel—melanoma	0.000571	0.00298	CcSEcCtD
Tamsulosin—Nervous system disorder—Temozolomide—melanoma	0.000569	0.00297	CcSEcCtD
Tamsulosin—Feeling abnormal—Bleomycin—melanoma	0.000567	0.00296	CcSEcCtD
Tamsulosin—Skin disorder—Temozolomide—melanoma	0.000564	0.00294	CcSEcCtD
Tamsulosin—Hypotension—Carmustine—melanoma	0.000561	0.00293	CcSEcCtD
Tamsulosin—Hyperhidrosis—Temozolomide—melanoma	0.000561	0.00292	CcSEcCtD
Tamsulosin—Fatigue—Dactinomycin—melanoma	0.000553	0.00288	CcSEcCtD
Tamsulosin—Pain—Dactinomycin—melanoma	0.000549	0.00286	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Carmustine—melanoma	0.000547	0.00285	CcSEcCtD
Tamsulosin—Urticaria—Bleomycin—melanoma	0.000547	0.00285	CcSEcCtD
Tamsulosin—Rhinitis—Docetaxel—melanoma	0.000545	0.00284	CcSEcCtD
Tamsulosin—Body temperature increased—Bleomycin—melanoma	0.000544	0.00284	CcSEcCtD
Tamsulosin—Insomnia—Carmustine—melanoma	0.000543	0.00283	CcSEcCtD
Tamsulosin—Paraesthesia—Carmustine—melanoma	0.000539	0.00281	CcSEcCtD
Tamsulosin—Pharyngitis—Docetaxel—melanoma	0.000539	0.00281	CcSEcCtD
Tamsulosin—Dyspnoea—Carmustine—melanoma	0.000536	0.00279	CcSEcCtD
Tamsulosin—Oedema peripheral—Docetaxel—melanoma	0.000535	0.00279	CcSEcCtD
Tamsulosin—Somnolence—Carmustine—melanoma	0.000534	0.00278	CcSEcCtD
Tamsulosin—Connective tissue disorder—Docetaxel—melanoma	0.000534	0.00278	CcSEcCtD
Tamsulosin—Feeling abnormal—Dactinomycin—melanoma	0.000529	0.00276	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000529	0.00276	CcSEcCtD
Tamsulosin—Insomnia—Temozolomide—melanoma	0.000525	0.00274	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Dactinomycin—melanoma	0.000525	0.00274	CcSEcCtD
Tamsulosin—Visual impairment—Docetaxel—melanoma	0.000524	0.00273	CcSEcCtD
Tamsulosin—Paraesthesia—Temozolomide—melanoma	0.000521	0.00272	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Carmustine—melanoma	0.000519	0.0027	CcSEcCtD
Tamsulosin—Dyspnoea—Temozolomide—melanoma	0.000518	0.0027	CcSEcCtD
Tamsulosin—Somnolence—Temozolomide—melanoma	0.000516	0.00269	CcSEcCtD
Tamsulosin—Erythema multiforme—Docetaxel—melanoma	0.000514	0.00268	CcSEcCtD
Tamsulosin—Constipation—Carmustine—melanoma	0.000514	0.00268	CcSEcCtD
Tamsulosin—Pain—Carmustine—melanoma	0.000514	0.00268	CcSEcCtD
Tamsulosin—Dyspepsia—Temozolomide—melanoma	0.000511	0.00266	CcSEcCtD
Tamsulosin—Abdominal pain—Dactinomycin—melanoma	0.000507	0.00264	CcSEcCtD
Tamsulosin—Body temperature increased—Dactinomycin—melanoma	0.000507	0.00264	CcSEcCtD
Tamsulosin—Hypersensitivity—Bleomycin—melanoma	0.000507	0.00264	CcSEcCtD
Tamsulosin—Cardiac disorder—Docetaxel—melanoma	0.000504	0.00263	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Temozolomide—melanoma	0.000501	0.00261	CcSEcCtD
Tamsulosin—Fatigue—Temozolomide—melanoma	0.0005	0.00261	CcSEcCtD
Tamsulosin—Constipation—Temozolomide—melanoma	0.000496	0.00259	CcSEcCtD
Tamsulosin—Pain—Temozolomide—melanoma	0.000496	0.00259	CcSEcCtD
Tamsulosin—Feeling abnormal—Carmustine—melanoma	0.000495	0.00258	CcSEcCtD
Tamsulosin—Asthenia—Bleomycin—melanoma	0.000494	0.00257	CcSEcCtD
Tamsulosin—Angiopathy—Docetaxel—melanoma	0.000493	0.00257	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Carmustine—melanoma	0.000491	0.00256	CcSEcCtD
Tamsulosin—Mediastinal disorder—Docetaxel—melanoma	0.00049	0.00255	CcSEcCtD
Tamsulosin—Chills—Docetaxel—melanoma	0.000488	0.00254	CcSEcCtD
Tamsulosin—Pruritus—Bleomycin—melanoma	0.000487	0.00254	CcSEcCtD
Tamsulosin—Arrhythmia—Docetaxel—melanoma	0.000485	0.00253	CcSEcCtD
Tamsulosin—Feeling abnormal—Temozolomide—melanoma	0.000478	0.00249	CcSEcCtD
Tamsulosin—Abdominal pain—Carmustine—melanoma	0.000475	0.00248	CcSEcCtD
Tamsulosin—Body temperature increased—Carmustine—melanoma	0.000475	0.00248	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Temozolomide—melanoma	0.000475	0.00247	CcSEcCtD
Tamsulosin—Malnutrition—Docetaxel—melanoma	0.000473	0.00247	CcSEcCtD
Tamsulosin—Hypersensitivity—Dactinomycin—melanoma	0.000473	0.00246	CcSEcCtD
Tamsulosin—Urticaria—Temozolomide—melanoma	0.000461	0.0024	CcSEcCtD
Tamsulosin—Asthenia—Dactinomycin—melanoma	0.00046	0.0024	CcSEcCtD
Tamsulosin—Body temperature increased—Temozolomide—melanoma	0.000459	0.00239	CcSEcCtD
Tamsulosin—Abdominal pain—Temozolomide—melanoma	0.000459	0.00239	CcSEcCtD
Tamsulosin—Back pain—Docetaxel—melanoma	0.000458	0.00238	CcSEcCtD
Tamsulosin—Hypersensitivity—Carmustine—melanoma	0.000443	0.00231	CcSEcCtD
Tamsulosin—Diarrhoea—Dactinomycin—melanoma	0.000439	0.00229	CcSEcCtD
Tamsulosin—Vomiting—Bleomycin—melanoma	0.000438	0.00228	CcSEcCtD
Tamsulosin—Rash—Bleomycin—melanoma	0.000434	0.00226	CcSEcCtD
Tamsulosin—Dermatitis—Bleomycin—melanoma	0.000433	0.00226	CcSEcCtD
Tamsulosin—Asthenia—Carmustine—melanoma	0.000431	0.00225	CcSEcCtD
Tamsulosin—Hypersensitivity—Temozolomide—melanoma	0.000428	0.00223	CcSEcCtD
Tamsulosin—Syncope—Docetaxel—melanoma	0.000424	0.00221	CcSEcCtD
Tamsulosin—Palpitations—Docetaxel—melanoma	0.000418	0.00218	CcSEcCtD
Tamsulosin—Asthenia—Temozolomide—melanoma	0.000416	0.00217	CcSEcCtD
Tamsulosin—Loss of consciousness—Docetaxel—melanoma	0.000416	0.00217	CcSEcCtD
Tamsulosin—Cough—Docetaxel—melanoma	0.000413	0.00215	CcSEcCtD
Tamsulosin—Diarrhoea—Carmustine—melanoma	0.000411	0.00214	CcSEcCtD
Tamsulosin—Pruritus—Temozolomide—melanoma	0.000411	0.00214	CcSEcCtD
Tamsulosin—Nausea—Bleomycin—melanoma	0.000409	0.00213	CcSEcCtD
Tamsulosin—Hypertension—Docetaxel—melanoma	0.000408	0.00213	CcSEcCtD
Tamsulosin—Vomiting—Dactinomycin—melanoma	0.000408	0.00213	CcSEcCtD
Tamsulosin—Rash—Dactinomycin—melanoma	0.000405	0.00211	CcSEcCtD
Tamsulosin—Arthralgia—Docetaxel—melanoma	0.000403	0.0021	CcSEcCtD
Tamsulosin—Myalgia—Docetaxel—melanoma	0.000403	0.0021	CcSEcCtD
Tamsulosin—Chest pain—Docetaxel—melanoma	0.000403	0.0021	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.0004	0.00208	CcSEcCtD
Tamsulosin—Dizziness—Carmustine—melanoma	0.000397	0.00207	CcSEcCtD
Tamsulosin—Diarrhoea—Temozolomide—melanoma	0.000397	0.00207	CcSEcCtD
Tamsulosin—Carvedilol—ABCB1—melanoma	0.000394	0.0488	CrCbGaD
Tamsulosin—Dizziness—Temozolomide—melanoma	0.000384	0.002	CcSEcCtD
Tamsulosin—Infection—Docetaxel—melanoma	0.000383	0.002	CcSEcCtD
Tamsulosin—Vomiting—Carmustine—melanoma	0.000382	0.00199	CcSEcCtD
Tamsulosin—Nausea—Dactinomycin—melanoma	0.000381	0.00199	CcSEcCtD
Tamsulosin—Shock—Docetaxel—melanoma	0.00038	0.00198	CcSEcCtD
Tamsulosin—Rash—Carmustine—melanoma	0.000379	0.00197	CcSEcCtD
Tamsulosin—Nervous system disorder—Docetaxel—melanoma	0.000379	0.00197	CcSEcCtD
Tamsulosin—Dermatitis—Carmustine—melanoma	0.000378	0.00197	CcSEcCtD
Tamsulosin—Tachycardia—Docetaxel—melanoma	0.000377	0.00196	CcSEcCtD
Tamsulosin—Headache—Carmustine—melanoma	0.000376	0.00196	CcSEcCtD
Tamsulosin—Skin disorder—Docetaxel—melanoma	0.000375	0.00195	CcSEcCtD
Tamsulosin—Vomiting—Temozolomide—melanoma	0.000369	0.00192	CcSEcCtD
Tamsulosin—Rash—Temozolomide—melanoma	0.000366	0.00191	CcSEcCtD
Tamsulosin—Dermatitis—Temozolomide—melanoma	0.000366	0.00191	CcSEcCtD
Tamsulosin—Headache—Temozolomide—melanoma	0.000364	0.0019	CcSEcCtD
Tamsulosin—Hypotension—Docetaxel—melanoma	0.000361	0.00188	CcSEcCtD
Tamsulosin—Nausea—Carmustine—melanoma	0.000357	0.00186	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000352	0.00183	CcSEcCtD
Tamsulosin—Insomnia—Docetaxel—melanoma	0.000349	0.00182	CcSEcCtD
Tamsulosin—Paraesthesia—Docetaxel—melanoma	0.000347	0.00181	CcSEcCtD
Tamsulosin—Nausea—Temozolomide—melanoma	0.000345	0.0018	CcSEcCtD
Tamsulosin—Dyspnoea—Docetaxel—melanoma	0.000344	0.00179	CcSEcCtD
Tamsulosin—Somnolence—Docetaxel—melanoma	0.000343	0.00179	CcSEcCtD
Tamsulosin—Dyspepsia—Docetaxel—melanoma	0.00034	0.00177	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Docetaxel—melanoma	0.000333	0.00174	CcSEcCtD
Tamsulosin—Fatigue—Docetaxel—melanoma	0.000333	0.00173	CcSEcCtD
Tamsulosin—Pain—Docetaxel—melanoma	0.00033	0.00172	CcSEcCtD
Tamsulosin—Constipation—Docetaxel—melanoma	0.00033	0.00172	CcSEcCtD
Tamsulosin—Feeling abnormal—Docetaxel—melanoma	0.000318	0.00166	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Docetaxel—melanoma	0.000316	0.00165	CcSEcCtD
Tamsulosin—Abdominal pain—Docetaxel—melanoma	0.000305	0.00159	CcSEcCtD
Tamsulosin—Body temperature increased—Docetaxel—melanoma	0.000305	0.00159	CcSEcCtD
Tamsulosin—Hypersensitivity—Docetaxel—melanoma	0.000284	0.00148	CcSEcCtD
Tamsulosin—Asthenia—Docetaxel—melanoma	0.000277	0.00144	CcSEcCtD
Tamsulosin—Pruritus—Docetaxel—melanoma	0.000273	0.00142	CcSEcCtD
Tamsulosin—Diarrhoea—Docetaxel—melanoma	0.000264	0.00138	CcSEcCtD
Tamsulosin—Dizziness—Docetaxel—melanoma	0.000255	0.00133	CcSEcCtD
Tamsulosin—Vomiting—Docetaxel—melanoma	0.000245	0.00128	CcSEcCtD
Tamsulosin—Rash—Docetaxel—melanoma	0.000243	0.00127	CcSEcCtD
Tamsulosin—Dermatitis—Docetaxel—melanoma	0.000243	0.00127	CcSEcCtD
Tamsulosin—Headache—Docetaxel—melanoma	0.000242	0.00126	CcSEcCtD
Tamsulosin—Nausea—Docetaxel—melanoma	0.000229	0.0012	CcSEcCtD
Tamsulosin—ADRA1A—Signaling by GPCR—MAPK1—melanoma	9.61e-06	6.31e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—EGFR—melanoma	9.61e-06	6.3e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PIK3CB—melanoma	9.56e-06	6.27e-05	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—PIK3CA—melanoma	9.53e-06	6.25e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MMP9—melanoma	9.53e-06	6.25e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MMP9—melanoma	9.53e-06	6.25e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—MAPK3—melanoma	9.52e-06	6.24e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—CDKN1A—melanoma	9.5e-06	6.23e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—CDKN1A—melanoma	9.5e-06	6.23e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—PTEN—melanoma	9.47e-06	6.21e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—PTEN—melanoma	9.47e-06	6.21e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GNA11—melanoma	9.44e-06	6.19e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—NFKB1—melanoma	9.43e-06	6.18e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—NFKB1—melanoma	9.43e-06	6.18e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—KRAS—melanoma	9.42e-06	6.18e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—PIK3CA—melanoma	9.39e-06	6.16e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—MAPK3—melanoma	9.39e-06	6.16e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MDM2—melanoma	9.35e-06	6.13e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAP2K1—melanoma	9.34e-06	6.12e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CD—melanoma	9.27e-06	6.08e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—MYC—melanoma	9.26e-06	6.07e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—AKT1—melanoma	9.24e-06	6.06e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—AKT1—melanoma	9.24e-06	6.06e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—FASN—melanoma	9.24e-06	6.06e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—ERBB2—melanoma	9.22e-06	6.05e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—FGF2—melanoma	9.22e-06	6.04e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—BRAF—melanoma	9.21e-06	6.04e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	9.19e-06	6.02e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CXCL8—melanoma	9.18e-06	6.02e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—HRAS—melanoma	9.12e-06	5.98e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CB—melanoma	9.1e-06	5.97e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—SLC5A5—melanoma	9.09e-06	5.96e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—KRAS—melanoma	9.08e-06	5.96e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—MAPK1—melanoma	9.06e-06	5.94e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—EGFR—melanoma	9.06e-06	5.94e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CB—melanoma	8.98e-06	5.89e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IGF1—melanoma	8.97e-06	5.89e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1B—melanoma	8.97e-06	5.88e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—MAPK1—melanoma	8.93e-06	5.86e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—EGFR—melanoma	8.93e-06	5.86e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PTGS2—melanoma	8.9e-06	5.84e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—FGF2—melanoma	8.88e-06	5.82e-05	CbGpPWpGaD
Tamsulosin—HTR1A—GPCR downstream signaling—AKT1—melanoma	8.87e-06	5.82e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CASP3—melanoma	8.79e-06	5.76e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL2—melanoma	8.78e-06	5.76e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GNAQ—melanoma	8.77e-06	5.76e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CD44—melanoma	8.77e-06	5.76e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CXCL8—melanoma	8.75e-06	5.74e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—IL6—melanoma	8.73e-06	5.73e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—HRAS—melanoma	8.69e-06	5.7e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAP2K1—melanoma	8.67e-06	5.69e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—PIK3CA—melanoma	8.66e-06	5.68e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MDM2—melanoma	8.62e-06	5.66e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CD—melanoma	8.62e-06	5.65e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—VEGFA—melanoma	8.56e-06	5.61e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—VEGFA—melanoma	8.56e-06	5.61e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—KRAS—melanoma	8.56e-06	5.61e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CCND1—melanoma	8.55e-06	5.61e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1B—melanoma	8.54e-06	5.6e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	8.53e-06	5.6e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—ERBB2—melanoma	8.5e-06	5.58e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—STAT3—melanoma	8.47e-06	5.56e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—STAT3—melanoma	8.47e-06	5.56e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CTNNB1—melanoma	8.47e-06	5.56e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—NRAS—melanoma	8.45e-06	5.54e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—NRAS—melanoma	8.45e-06	5.54e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—AKT1—melanoma	8.45e-06	5.54e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—KRAS—melanoma	8.44e-06	5.53e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—CYP1B1—melanoma	8.41e-06	5.52e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CB—melanoma	8.39e-06	5.5e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CASP3—melanoma	8.37e-06	5.49e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL2—melanoma	8.36e-06	5.48e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	8.34e-06	5.47e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—IL6—melanoma	8.32e-06	5.45e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MDM2—melanoma	8.31e-06	5.45e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MMP9—melanoma	8.31e-06	5.45e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—CDKN1A—melanoma	8.28e-06	5.43e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PTEN—melanoma	8.26e-06	5.42e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—FGF2—melanoma	8.25e-06	5.41e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—NFKB1—melanoma	8.22e-06	5.39e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—ERBB2—melanoma	8.19e-06	5.37e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CCND1—melanoma	8.15e-06	5.34e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MAPK3—melanoma	8.1e-06	5.31e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MAPK3—melanoma	8.1e-06	5.31e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CB—melanoma	8.08e-06	5.3e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CTNNB1—melanoma	8.07e-06	5.29e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CXCL8—melanoma	8.06e-06	5.29e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—AKT1—melanoma	8.06e-06	5.28e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—HRAS—melanoma	8.01e-06	5.25e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MMP9—melanoma	7.91e-06	5.19e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—CDKN1A—melanoma	7.88e-06	5.17e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MYC—melanoma	7.87e-06	5.16e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MYC—melanoma	7.87e-06	5.16e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1B—melanoma	7.87e-06	5.16e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PTEN—melanoma	7.86e-06	5.16e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—PIK3CA—melanoma	7.86e-06	5.16e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—NFKB1—melanoma	7.83e-06	5.13e-05	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—AKT1—melanoma	7.79e-06	5.11e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CXCL8—melanoma	7.77e-06	5.09e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PTEN—melanoma	7.76e-06	5.09e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	7.75e-06	5.08e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MDM2—melanoma	7.72e-06	5.06e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—HRAS—melanoma	7.72e-06	5.06e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CASP3—melanoma	7.72e-06	5.06e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL2—melanoma	7.71e-06	5.05e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MAPK1—melanoma	7.7e-06	5.05e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MAPK1—melanoma	7.7e-06	5.05e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—EGFR—melanoma	7.7e-06	5.05e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—EGFR—melanoma	7.7e-06	5.05e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—AKT1—melanoma	7.67e-06	5.03e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—IL6—melanoma	7.67e-06	5.03e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CG—melanoma	7.64e-06	5.01e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—ERBB2—melanoma	7.61e-06	4.99e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TP53—melanoma	7.6e-06	4.99e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1B—melanoma	7.59e-06	4.98e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CCND1—melanoma	7.51e-06	4.93e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CB—melanoma	7.51e-06	4.93e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—AKT1—melanoma	7.5e-06	4.92e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—VEGFA—melanoma	7.46e-06	4.89e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CTNNB1—melanoma	7.44e-06	4.88e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CASP3—melanoma	7.43e-06	4.88e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL2—melanoma	7.42e-06	4.87e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—IL6—melanoma	7.39e-06	4.84e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—STAT3—melanoma	7.38e-06	4.84e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PPARG—melanoma	7.37e-06	4.84e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—NRAS—melanoma	7.37e-06	4.83e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MMP9—melanoma	7.29e-06	4.78e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—KRAS—melanoma	7.28e-06	4.77e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—KRAS—melanoma	7.28e-06	4.77e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—HRAS—melanoma	7.27e-06	4.77e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—CDKN1A—melanoma	7.27e-06	4.77e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PTEN—melanoma	7.25e-06	4.76e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CCND1—melanoma	7.24e-06	4.75e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CXCL8—melanoma	7.22e-06	4.73e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—NFKB1—melanoma	7.22e-06	4.73e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—HRAS—melanoma	7.17e-06	4.7e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CTNNB1—melanoma	7.17e-06	4.7e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—VEGFA—melanoma	7.1e-06	4.66e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—AKT1—melanoma	7.07e-06	4.64e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MAPK3—melanoma	7.06e-06	4.63e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1B—melanoma	7.05e-06	4.62e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—STAT3—melanoma	7.03e-06	4.61e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MMP9—melanoma	7.03e-06	4.61e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—NRAS—melanoma	7.02e-06	4.6e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—CDKN1A—melanoma	7e-06	4.59e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PTEN—melanoma	6.98e-06	4.58e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—AKT1—melanoma	6.97e-06	4.57e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—IL6—melanoma	6.96e-06	4.57e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—NFKB1—melanoma	6.95e-06	4.56e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ABCB1—melanoma	6.93e-06	4.54e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CASP3—melanoma	6.91e-06	4.53e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL2—melanoma	6.9e-06	4.52e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—IL6—melanoma	6.86e-06	4.5e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MYC—melanoma	6.86e-06	4.5e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—AKT1—melanoma	6.81e-06	4.47e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CCND1—melanoma	6.72e-06	4.41e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MAPK3—melanoma	6.72e-06	4.41e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CD—melanoma	6.71e-06	4.4e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MAPK1—melanoma	6.71e-06	4.4e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—EGFR—melanoma	6.71e-06	4.4e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—PIK3CA—melanoma	6.68e-06	4.38e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—PIK3CA—melanoma	6.68e-06	4.38e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CTNNB1—melanoma	6.66e-06	4.37e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—ALB—melanoma	6.63e-06	4.35e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—VEGFA—melanoma	6.55e-06	4.3e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MYC—melanoma	6.53e-06	4.29e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MMP9—melanoma	6.53e-06	4.28e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—CDKN1A—melanoma	6.5e-06	4.27e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PTEN—melanoma	6.49e-06	4.26e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—STAT3—melanoma	6.48e-06	4.25e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—NRAS—melanoma	6.47e-06	4.24e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TP53—melanoma	6.47e-06	4.24e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TP53—melanoma	6.47e-06	4.24e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—NFKB1—melanoma	6.46e-06	4.24e-05	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—AKT1—melanoma	6.42e-06	4.21e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MAPK1—melanoma	6.39e-06	4.19e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—EGFR—melanoma	6.39e-06	4.19e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PRKCA—melanoma	6.38e-06	4.18e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—KRAS—melanoma	6.34e-06	4.16e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—AKT1—melanoma	6.33e-06	4.15e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ERCC2—melanoma	6.32e-06	4.15e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—VEGFA—melanoma	6.31e-06	4.14e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—STAT3—melanoma	6.25e-06	4.1e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—NRAS—melanoma	6.23e-06	4.09e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MAPK3—melanoma	6.19e-06	4.06e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—HRAS—melanoma	6.18e-06	4.06e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—HRAS—melanoma	6.18e-06	4.06e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—KRAS—melanoma	6.04e-06	3.96e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MYC—melanoma	6.02e-06	3.95e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAPK3—melanoma	5.97e-06	3.91e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—IL6—melanoma	5.92e-06	3.88e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—IL6—melanoma	5.92e-06	3.88e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MAPK1—melanoma	5.89e-06	3.87e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—EGFR—melanoma	5.89e-06	3.87e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—VEGFA—melanoma	5.86e-06	3.84e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CB—melanoma	5.85e-06	3.84e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—PIK3CA—melanoma	5.83e-06	3.82e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MYC—melanoma	5.8e-06	3.81e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—STAT3—melanoma	5.8e-06	3.81e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PTGS2—melanoma	5.8e-06	3.8e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—NRAS—melanoma	5.79e-06	3.8e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MAPK1—melanoma	5.68e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—EGFR—melanoma	5.68e-06	3.72e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TP53—melanoma	5.64e-06	3.7e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—KRAS—melanoma	5.57e-06	3.65e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—PIK3CA—melanoma	5.55e-06	3.64e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAPK3—melanoma	5.55e-06	3.64e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PIK3CA—melanoma	5.48e-06	3.59e-05	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—AKT1—melanoma	5.46e-06	3.58e-05	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—AKT1—melanoma	5.46e-06	3.58e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MYC—melanoma	5.39e-06	3.54e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—HRAS—melanoma	5.39e-06	3.53e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TP53—melanoma	5.37e-06	3.52e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—KRAS—melanoma	5.36e-06	3.52e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MAPK1—melanoma	5.28e-06	3.46e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—EGFR—melanoma	5.28e-06	3.46e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL6—melanoma	5.16e-06	3.38e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—HRAS—melanoma	5.13e-06	3.37e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—PIK3CA—melanoma	5.11e-06	3.35e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PTEN—melanoma	5.06e-06	3.32e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CG—melanoma	4.99e-06	3.28e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—KRAS—melanoma	4.98e-06	3.27e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TP53—melanoma	4.95e-06	3.25e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—PIK3CA—melanoma	4.93e-06	3.23e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL6—melanoma	4.91e-06	3.22e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PPARG—melanoma	4.82e-06	3.16e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TP53—melanoma	4.77e-06	3.13e-05	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—AKT1—melanoma	4.76e-06	3.12e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—HRAS—melanoma	4.73e-06	3.1e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—PIK3CA—melanoma	4.58e-06	3e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—HRAS—melanoma	4.56e-06	2.99e-05	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—AKT1—melanoma	4.53e-06	2.97e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL6—melanoma	4.53e-06	2.97e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—AKT1—melanoma	4.47e-06	2.93e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TP53—melanoma	4.43e-06	2.91e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CD—melanoma	4.39e-06	2.88e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL6—melanoma	4.36e-06	2.86e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ALB—melanoma	4.33e-06	2.84e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—HRAS—melanoma	4.24e-06	2.78e-05	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—AKT1—melanoma	4.18e-06	2.74e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL6—melanoma	4.05e-06	2.66e-05	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—AKT1—melanoma	4.03e-06	2.64e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CB—melanoma	3.83e-06	2.51e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PTGS2—melanoma	3.79e-06	2.49e-05	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—AKT1—melanoma	3.74e-06	2.45e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PIK3CA—melanoma	3.57e-06	2.34e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PTEN—melanoma	3.31e-06	2.17e-05	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—AKT1—melanoma	2.91e-06	1.91e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PIK3CA—melanoma	2.33e-06	1.53e-05	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—AKT1—melanoma	1.91e-06	1.25e-05	CbGpPWpGaD
